Brian Klein, M.D. joined Stifel, Nicolaus & Co., Inc. in 2012 and is a Vice President in the health care sector, covering biotechnology. Before joining Stifel, Nicolaus & Co., Inc., Dr. Klein was an Analyst with Lazard Capital Markets, and a Medical Resident at St. Luke’s-Roosevelt Hospital. He remains board-certified in internal medicine. Dr. Klein is a graduate of Yale University, earned an M.S. in physiology and biophysics from Georgetown University, and an M.D. from New York Medical College.
Clinical Advancements and Drug Launches in Therapeutics Fuel Investor Enthusiasm
August 19, 2014